Publications by authors named "Keith D Eaton"

Claim this Profile
O
Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer.
Kevin M Levine, Natalie F Uy, Ted A Gooley, Jenna Voutsinas, Micah Tratt, Keith D Eaton

Cancer Treat Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers.
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, Jenna Voutsinas, Jonathan R Fromm, Keith D Eaton

Head Neck· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy.
Micah Tratt, Anshu Bandhlish, Keith D Eaton, Ted Gooley, Nicholas Giustini

JTO Clin Res Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.
Natalie J Miller, Christina Baik, Joel W Neal, Fangdi Sun, Rafael Santana-Davila, Keith D Eaton

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis.
Ann Oluloro, David L Wells, Charles K Childers, Tiffany Luu, Keith D Eaton

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.
Natalie J Miller, Christina S Baik, Joel W Neal, Fangdi Sun, Rafael Santana-Davila, Keith D Eaton

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Mitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, Leora Horn, D Ross Camidge, Keith D Eaton

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.
Lyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, Sanjay Goel, Rebecca Heist, Keith D Eaton

Future Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions.
Mark Edward Jao, Amy Ly Indorf, Eve-Michelle Segal, Abby Miske, Keith David Eaton

J Oncol Pharm Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study.
Melissa L Johnson, James Strauss, Manish R Patel, Edward B Garon, Keith D Eaton

Clin Lung Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Line Patency: Management With Normal Saline Flushes for Adult Patients With Cancer.
Grace Baek, Phuong Huynh, Terri Cunningham, Keith D Eaton, Simran Ghuman

Clin J Oncol Nurs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Cameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, Rafael Santana-Davila, Victoria Hwang, Keith D Eaton

Cancer Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Neuropathic Arthropathy With Entrectinib: Case Report.
Nicholas P Giustini, Hanna Oh, Keith D Eaton

JTO Clin Res Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.
Perrin E Romine, Qin Sun, Catherine Fedorenko, Li Li, Mariel Tang, Keith D Eaton

JCO Oncol Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, Qian Vicky Wu, Victoria Hwang, Keith D Eaton

J Palliat Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy.
Christina Baik, Sylvia Lee, Kitty Cook, Sarah Wallace, Rebecca Wood, Keith D Eaton

Cancer Treat Res Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
Perrin E Romine, Jenna Voutsinas, Vicky Wu, Micah Tratt, Jay Liao, Keith D Eaton

Oral Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
Cristina M Merkhofer, Keith D Eaton, Renato G Martins, Scott D Ramsey, Bernardo H L Goulart

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Stephen R Bowen, Daniel S Hippe, Hannah M Thomas, Balukrishna Sasidharan, Paul D Lampe, Keith D Eaton

Adv Radiat Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.
Keith D Eaton, Perrin E Romine, Renato G Martins, Antoine Leblond, Laurie L Carr

Cureus· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.
Cristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D Eaton, Renato G Martins

JCO Oncol Pract· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity.
Eli Grunblatt, Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P Norton, Keith D Eaton

Genes Dev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Keith D Eaton

J Immunother Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone-Secreting Adrenocortical Carcinoma Presenting With Cardiac Arrest.
Nicole K Zern, Keith D Eaton, Mara Y Roth

J Endocr Soc· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
Arnaud Augert, Emily Eastwood, Ali H Ibrahim, Nan Wu, Eli Grunblatt, Keith D Eaton

Sci Signal· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis